To this end, we hypothesized that our previously published data showing SHP2 as an anti-fibrotic mediator in the context of lung fibrosis [12] could be partially explained by the negative regulation of fibroblast mitochondrial homeostasis, leading to ineffective mitochondrial metabolism and disrupted fibrotic responses. The gene discussed is PTPN11; the disease is pulmonary fibrosis.